|
YWHAQ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.704400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.052580E-01 |
| Normal-vs-Stage2 |
6.527600E-01 |
| Normal-vs-Stage3 |
9.152400E-01 |
| Normal-vs-Stage4 |
6.309600E-01 |
| Stage1-vs-Stage2 |
1.474230E-01 |
| Stage1-vs-Stage3 |
3.150400E-01 |
| Stage1-vs-Stage4 |
1.747410E-01 |
| Stage2-vs-Stage3 |
6.303200E-01 |
| Stage2-vs-Stage4 |
8.289800E-01 |
| Stage3-vs-Stage4 |
5.436200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.974600E-01 |
| Normal-vs-AfricanAmerican |
7.403800E-01 |
| Normal-vs-Asian |
5.138600E-01 |
| Caucasian-vs-AfricanAmerican |
6.023000E-01 |
| Caucasian-vs-Asian |
9.026800E-01 |
| AfricanAmerican-vs-Asian |
7.644400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.733700E-02 |
| Normal-vs-Female |
9.183700E-02 |
| Male-vs-Female |
3.376600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.224020E-01 |
| Normal-vs-Extreme_Weight |
4.274100E-02 |
| Normal-vs-Obese |
8.541800E-01 |
| Normal-vs-Extreme_Obese |
3.271200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.535600E-01 |
| Normal_Weight-vs-Obese |
1.122370E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.922200E-01 |
| Extreme_Weight-vs-Obese |
3.772200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.448200E-01 |
| Obese-vs-Extreme_Obese |
2.087200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.788200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.144800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.013010E-01 |
| Normal-vs-Age(81-100Yrs) |
1.453010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.709600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.795200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.823000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.059700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.629000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.487200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.526400E-01 |
| Normal-VS-Type2 PRCC |
7.452400E-02 |
| Normal-VS-KIRP CIMP |
4.493600E-01 |
| Normal-VS-Unclassified PRCC |
4.928000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.808200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.156800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.464380E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.913600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.743700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.776000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.079900E-02 |
| Normal-vs-N1 |
4.709800E-01 |
| Normal-vs-N2 |
6.891600E-01 |
| N0-vs-N1 |
2.018200E-02 |
| N0-vs-N2 |
2.563000E-01 |
| N1-vs-N2 |
9.320000E-01 |
|
|
